Cascade Investment Group’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$376K Sell
3,664
-23
-0.6% -$2.6K 0.25% 101
2025
Q4
$462K Hold
3,687
0.31% 76
2025
Q3
$494K Hold
3,687
0.33% 70
2025
Q2
$501K Buy
3,687
+223
+6% +$29.4K 0.35% 65
2025
Q1
$460K Buy
3,464
+119
+4% +$15.1K 0.35% 65
2024
Q4
$378K Buy
3,345
+802
+32% +$92.7K 0.27% 82
2024
Q3
$290K Buy
+2,543
New +$279K 0.21% 106
2024
Q2
Sell
-3,066
Closed -$348K 130
2024
Q1
$348K Hold
3,066
0.26% 88
2023
Q4
$337K Buy
3,066
+59
+2% +$5.89K 0.27% 82
2023
Q3
$291K Hold
3,007
0.27% 86
2023
Q2
$328K Hold
3,007
0.3% 84
2023
Q1
$304K Hold
3,007
0.3% 89
2022
Q4
$330K Buy
+3,007
New +$311K 0.34% 82

Other funds holding ABT

Cascade Investment Group's ABT Position: Q1 2026 in Review

Cascade Investment Group reduced its Abbott (ABT) stake by 0.62% in Q1 2026, selling an estimated $2.6K and leaving 3,664 shares worth $376K. The position accounts for 0.25% of the portfolio, ranked #101.

Cascade Investment Group first reported a position in ABT in Q4 2022 and has held it in 13 quarters since. The position peaked at $501K in Q2 2025. 3,083 funds tracked by Wall St. Rank hold ABT as of Q1 2026.

  • Cascade Investment Group held 3,664 shares of Abbott worth $376K as of Q1 2026.
  • Cascade Investment Group sold 23 Abbott shares in Q1 2026, an estimated $2.6K.
  • Abbott made up 0.25% of Cascade Investment Group's portfolio in Q1 2026, its #101 holding.
  • Cascade Investment Group first reported a position in Abbott in Q4 2022 and has held it in 13 quarters since.
  • Cascade Investment Group's Abbott position peaked at $501K in Q2 2025.
  • 3,083 funds tracked by Wall St. Rank held Abbott as of Q1 2026.

Based on Cascade Investment Group's 13F filing for Q1 2026, filed 13 May 2026.